BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Holistic medicine
,
Doxorubicin
,
rs2230926
,
GATA1
,
Angiogenesis
,
Inflammatory disorder
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
G1 cell size control checkpoint
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
No diseases found
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
latrunculin A
Hydrogen Peroxide
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
SET2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
S. pombe exposed to oxidative conditions via hydrogen peroxide treatment
S. pombe KLF1 knockout cells in induced G0 phase
Expression in histone methyltransferase mutants in yeast
Rep2 mutant fission yeast expression profiling upon hydroxyurea treatment
Expression profiling of wild-type and set3 KO fission yeast strains
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for G1 cell size control checkpoint
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients …
Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythe…
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma
Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers
Durvalumab and Tremelimumab in Resectable HCC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ